A RARE VARIANT OF IMMUNE INCOMPATIBILITY OF MOTHER AND FETUS FOR “MINOR” ERYTHROCYTE ANTIGENS
https://doi.org/10.48612/agmu/2022.17.4.151.156
Abstract
The article represents a rare case of hemolytic disease of the newborn because of incompatibility for other antigens of the Rh system (C, c, E, e). Attention is focused on the need to follow the recommendations on frequency and methods of examination for the timely diagnosis of hemolytic disease of the fetus due to Rh immunization of mother, as well as delivery in obstetric hospitals that can provide an adequate level of therapy care in hemolytic disease of the newborn. The need for further research in antenatal diagnostics of immunological incompatibility between mother and fetus due to the so-called “minor” erythrocyte antigens is shown.
Keywords
erythrocyte antigens,
Rh immunization,
hemolytic disease of the fetus,
hemolytic disease of the newborn
Supporting agencies: The authors declare that there is no external funding for the exploration and analysis work.
About the Authors
I. V. Telegina
Astrakhan State Medical University
Russian Federation
Russian Federation
Irina V. Telegina, Cand. Sci. (Med.), Assistant
Astrakhan
E. E. Andreeva
Astrakhan State Medical University
Russian Federation
Russian Federation
Elena E. Andreeva, Cand. Sci. (Med.), Associate Professor of Department
Astrakhan
I. A. Dudina
Clinical Maternity Hospital named after Yu.A. Paskhalova
Russian Federation
Russian Federation
Irina A. Dudina, Head of Department
Astrakhan
S. P. Sinchikhin
Astrakhan State Medical University
Russian Federation
Russian Federation
Sergey P. Sinchikhin, Dr. Sci. (Med.), Professor, Head of Department
Astrakhan
R. V. Pavlov
Municipal Clinical Hospital No. 3 named after S.M. Kirov;
Astrakhan State Medical University
Russian Federation
Russian Federation
Roman V. Pavlov, Dr. Sci. (Med.), Head of Department; Associate Professor of Department
Astrakhan
S. V. Lapeko
Clinical Maternity Hospital named after Yu.A. Paskhalova;
Astrakhan State Medical University
Russian Federation
Russian Federation
Svetlana V. Lapeko, Cand. Sci. (Med.), Head of Department; Assistant
Astrakhan
E. V. Kruglova
Clinical Maternity Hospital named after Yu.A. Paskhalova
Russian Federation
Russian Federation
Elena V. Kruglova, Specialist of clinical laboratory diagnostics
Astrakhan
D. R. Yulusheva
Clinical Maternity Hospital named after Yu. A. Paskhalova
Russian Federation
Russian Federation
Dilyara R. Yulusheva, obstetrician-gynecologist
Astrakhan
References
1. Neonatology. National guidance. Brief edition / eds. by Volodin N. N. M. : GEOTAR-Media, 2019. 887 p. (In Russ.).
2. Rh isoimmunization. Hemolytic disease of the fetus. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow. 2020, 38 p. (In Russ.).
3. Shejbak L. N. S Modern features of hemolytic disease of the fetus and newborn. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta = Journal of the Grodno State Medical University. 2015; 1: 134–135. (In Russ.).
4. Butina E. V., Zajceva G. A. Allosensitization to erythrocyte antigens in women of reproductive age. Vyatskiy meditsinskiy vestnik = Vyatka medical bulletin. 2016; 50 (2): 32–34. (In Russ.).
5. Haider M., Memon S., Tariq F., Fatima S., Hameed A. Rhesus Isoimmunization: Late-onset Hemolytic Disease of the Newborn Without Jaundice // Cureus. 2020; 12(1): e6559.
6. Fyfe T. M., Ritchey M. J., Christorina T. Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review. BMC Pregnancy Childbirth. 2014; 14 (1): 11.
7. Delaney M., Matthews D. C. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology. 2015; 2015 (1): 146–151.
8. Normal pregnancy. Clinical recommendations of the Ministry of Health of the Russian Federation. Moscow. 2020, 80 p. (In Russ.).
9. Shishko G. A., Serzhan T. A., Artyushevskaya M. V., Sapotnitsky A. V., Kozlyakova O. V., Kamalova O. I. The use of modern methods for typing erythrocyte antigens according to the Rhesus system in pregnant women and of their children to optimize the diagnosis and treatment of hemolytic disease of the newborn. Transfusiogiya = Transfusiology. 2010. 2(1): 20–24. (In Russ.).
10. Manevich-Mazor M., Weissmann-Brenner A., Bar Yosef O., Hoffmann C., Mazor R. D., Mosheva M., Achiron R. R., Katorza E. Added Value of Fetal MRI in the Evaluation of Fetal Anomalies of the Corpus Callosum: A Retrospective Analysis of 78 Cases. Ultraschall in der Medizin. 2018. 39 (5): 513–525. doi: 10.1055/s-0043-113820.
11. Savelyeva G. M., Sukhikh G. T., Serov V. N., Radzinsky V. E., eds. Obstetrics. National guidance. Moscow: GEOTAR-Media; 2018. 1080 p.
Review
For citations:
Telegina I.V., Andreeva E.E., Dudina I.A., Sinchikhin S.P., Pavlov R.V., Lapeko S.V., Kruglova E.V., Yulusheva D.R. A RARE VARIANT OF IMMUNE INCOMPATIBILITY OF MOTHER AND FETUS FOR “MINOR” ERYTHROCYTE ANTIGENS. Astrakhan medical journal. 2022;17(4):151-156. (In Russ.) https://doi.org/10.48612/agmu/2022.17.4.151.156
Views:
266
Email this article 